Suppr超能文献

老年重度二叶式主动脉瓣狭窄患者经导管主动脉瓣置换术后复发性中风:一例报告

Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report.

作者信息

Meng Xuyang, Wang Xiang, Yang Chenguang, Zhang Huiping, Zhong You, Wang Fang

机构信息

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Graduate School of Peking Union Medical College, Chinese Academy of Medical Science, Beijing, 100730, China.

出版信息

BMC Cardiovasc Disord. 2024 Dec 20;24(1):731. doi: 10.1186/s12872-024-04392-y.

Abstract

BACKGROUND

Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Recently, its use has also been extended to low-risk patients, resulting in its increasing utilization in patients with bicuspid aortic valve (BAV). But as a serious post-TAVR complication, ischemic stroke was associated with a nearly 6-fold increased 30-day mortality. BAV presents unique challenges for post-TAVR antithrombotic therapy due to its distinct valvular anatomy.

CASE PRESENTATION

We present a case of a 72-year-old female who presented with angina pectoris symptoms and was found to have severe BAV stenosis (Type 0). According to the patient's age, obvious symptom and willingness herself, TAVR was successful performed with deployment of a 23 mm Venus-A Plus valve (Venus Medtech, Hangzhou, China). A post-procedure echocardiogram confirmed the appropriate placement of the bioprosthetic valve with minor paravalvular regurgitation. Six months after TAVR, this patient experienced multiple strokes, presenting a significant challenge for clinicians.

CONCLUSIONS

This case underscores the serious complications that can occur post-TAVR and highlights the need for improved strategies to prevent early strokes.

摘要

背景

经导管主动脉瓣置换术(TAVR)已从一项新技术发展成为治疗有症状的重度主动脉瓣狭窄(AS)高危患者的既定疗法。最近,其应用也已扩展到低危患者,导致其在二叶式主动脉瓣(BAV)患者中的使用越来越多。但作为TAVR术后的一种严重并发症,缺血性卒中与30天死亡率增加近6倍相关。由于其独特的瓣膜解剖结构,BAV给TAVR术后抗栓治疗带来了独特的挑战。

病例介绍

我们报告一例72岁女性患者,该患者出现心绞痛症状,被发现患有重度BAV狭窄(0型)。根据患者年龄、明显症状及自身意愿,成功进行了TAVR,植入一枚23mm Venus-A Plus瓣膜(杭州启明医疗器械股份有限公司,中国杭州)。术后超声心动图证实生物瓣膜位置合适,仅有轻微瓣周反流。TAVR术后6个月,该患者发生多次卒中,给临床医生带来了重大挑战。

结论

该病例强调了TAVR术后可能发生的严重并发症,并突出了改进预防早期卒中策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45a7/11660585/c63621d41aa5/12872_2024_4392_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验